Published On: 30 Oct, 2020 6:43 PM | Updated On: 26 Dec, 2024 8:20 PM
NAFLD & Diabetes
An initiative by Medtalks, in association with Mankind Pharma to bring to you new findings from key trials, in the prevention and management of diabetes.
In this Issue 2 we will discuss about NAFLD and SGLT2 inhibitors. NAFLD is closely linked with type 2 diabetes. The role of SGLT2 inhibitors; Justification; Current trials status; Future of SGLT2i in NAFLD; Currently available drugs for NAFLD. A recent research has shown that patients with NAFLD have a higher risk of diabetes, and the more severe the disease the greater the risk.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article